A single administration of DNA-encoded trispecific T cell engager (DTriTE) targeting EGFRvIII, IL13Ra2, and CD3 shows complete tumor clearance in an orthotopic challenge model of heterogeneous GBM

被引：0
|
作者：
Park, Daniel Hongil
Bhojnagarwala, Pratik
Liaw, Kevin
Bordoloi, Devivasha
Gary, Ebony N.
Weiner, David B.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2976
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2976
引用
收藏
页数：2
相关论文
共 3 条
  • [1] EGFRvIII-Targeting DNA-Encoded Immune Cell Engager (DICE) Generates In Vivo Expression of Bispecific Antibody that Induces T Cell-Mediated Cytolytic Activities Against EGFRvIII-Positive Tumors and Controls Tumor Growth in a GBM Mouse Model
    Park, Daniel H.
    Perales-Puchalt, Alfredo
    Bhojnagarwala, Pratik
    Gary, Ebony N.
    Zhu, Xizhou
    Patel, Ami
    Yun, Kun
    Smith, Trevor
    Muthumani, Kar
    Weiner, David B.
    MOLECULAR THERAPY, 2020, 28 (04) : 497 - 497
  • [2] In vivo DNA-launched bispecific T cell engager targeting IL-13Ra2 controls tumor growth in an animal model of glioblastoma multiforme
    Bhojnagarwala, Pratik S.
    O'Connell, Ryan P.
    Park, Daniel
    Liaw, Kevin
    Ali, Ali R.
    Bordoloi, Devivasha
    Cassel, Joel
    Tursi, Nicholas J.
    Gary, Ebony
    Weiner, David B.
    MOLECULAR THERAPY ONCOLYTICS, 2022, 26 : 289 - 301
  • [3] Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells
    Park, Daniel H.
    Bhojnagarwala, Pratik S.
    Liaw, Kevin
    Bordoloi, Devivasha
    Tursi, Nicholas J.
    Zhao, Shushu
    Binder, Zev A.
    O'Rourke, Donald
    Weiner, David B.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (12)
1